TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 4, 2014, Pages 2747-2756

  Tong, Jun ^a   Fu, Yuxuan ^b   Xu, Xinyu ^a   Fan, Shuxin ^a   Sun, Hong ^a   Liang, Ya ^a   Xu, Kai ^a   Yuan, Zhilan ^a   Ge, Yingbin ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Glaucoma; Human Tenon's capsule fibroblasts; MicroRNA 200b; TGF 1

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLINE; EDOXUDINE; MICRORNA; MICRORNA 200B; TRANSFORMING GROWTH FACTOR BETA1;

3' UNTRANSLATED REGION; ARTICLE; CELL COUNTING; CELL CYCLE; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENON CAPSULE; WESTERN BLOTTING;

CELL PROLIFERATION; GLAUCOMA; HUMAN TENON'S CAPSULE FIBROBLASTS; MICRORNA-200B; TGF-Β1;

BLOTTING, WESTERN; CELL COUNT; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FIBROBLASTS; GENE EXPRESSION REGULATION; GLAUCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RNA; TENON CAPSULE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84899679116     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13422     Document Type: Article

References (46)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82:844-851.
2. O'Brien C, Schwartz B, Takamoto T, Wu DC. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 1991;111:491-500.
3. Freiberg FJ, Matlach J, Grehn F, Karl S, Klink T. Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy. Clin Ophthalmol. 2013;7:1211-1217.
4. Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol. 2012;57:530-550.
5. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101:1651-1656, discussion 1657.
6. Chung EJ, Lee HK, Jung SA, et al. Transduction of PTEN proteins using the tat domain modulates TGF-beta1-mediated signaling pathways and transdifferentiation in subconjunctival fibroblasts. Invest Ophthalmol Vis Sci. 2012;53:379-386.
7. Fuchshofer R, Kottler UB, Ohlmann AV, et al. SPARC is expressed in scars of the Tenon's capsule and mediates scarring properties of human Tenon's fibroblasts in vitro. Mol Vis. 2011;17:177-185.
8. Schlotzer-Schrehardt U, Zenkel M, Kuchle M, Sakai LY, Naumann GO. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
9. Bowen T, Jenkins RH, Fraser DJ. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol. 2013;229: 274-285.
10. Yang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180:484-493.
11. Zhou H, Hasni SA, Perez P, et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24:1073-1087.
12. Maes OC, Sarojini H, Wang E. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol. 2009;221:109-119.
13. Hawkins SM, Creighton CJ, Han DY, et al. Functional micro-RNA involved in endometriosis. Mol Endocrinol. 2011;25: 821-832.
14. Luna C, Li G, Qiu J, Epstein DL, Gonzalez P. MicroRNA-24 regulates the processing of latent TGFbeta1 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN. J Cell Physiol. 2011;226: 1407-1414.
15. Li N, Cui J, Duan X, Chen H, Fan F. Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon's fibroblasts. Invest Ophthalmol Vis Sci. 2012;53:1670-1678.
16. Feng B, Wang R, Chen LB. Review of miR-200b and cancer chemosensitivity. Biomed Pharmacother. 2012;66:397-402.
17. Patel V, Noureddine L. MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens. 2012;21:410-416.
18. Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest. 1999;103:597-604.
19. Larrea MD, Wander SA, Slingerland JM. P27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle. 2009;8: 3455-3461.
20. Xia W, Li J, Chen L, et al. MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol Cell Biochem. 2010;344:261-266.
21. Riou P, Villalonga P, Ridley AJ. Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression. Bioessays. 2010;32:986-992.
22. Uhlmann S, Zhang JD, Schwager A, et al. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010;29:4297-4306.
23. Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14:2690-2695.
24. Tang W, Zhang Y, Qian C, Yuan Z, Du J. Induction and mechanism of apoptosis by hydroxycamptothecin in human Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci. 2012; 53:4874-4880.
25. Kay EP, Lee HK, Park KS, Lee SC. Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts. Invest Ophthalmol Vis Sci. 1998; 39:481-486.
26. Cordeiro MF, Bhattacharya SS, Schultz GS, Khaw PT. TGFbeta1,-beta2, and-beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci. 2000;41:756-763.
27. Chu I, Sun J, Arnaout A, et al. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell. 2007;128:281-294.
28. Chardin P. Function and regulation of Rnd proteins. Nat Rev Mol Cell Biol. 2006;7:54-62.
29. Cordeiro MF. Beyond Mitomycin: TGF-beta and wound healing. Prog Retin Eye Res. 2002;21:75-89.
30. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1-7.
31. Ravitz MJ, Yan S, Dolce C, Kinniburgh AJ, Wenner CE. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts. J Cell Physiol. 1996; 168:510-520.
32. Chen SC, Guh JY, Lin TD, et al. Gefitinib attenuates transforming growth factor-beta1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells. Transl Res. 2011;158:214-224.
33. Wang S, Wilkes MC, Leof EB, Hirschberg R. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J. 2005;19:1-11.
34. Liu X, Wen FQ, Kobayashi T, et al. Smad3 mediates the TGFbeta-induced contraction of type I collagen gels by mouse embryo fibroblasts. Cell Motil Cytoskeleton. 2003;54:248-253.
35. Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci. 2012;53:241-247.
36. Fuchshofer R, Tamm ER. The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 2012;347:279-290.
37. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295-309.
38. Siriwardena D, Khaw PT, King AJ, et al. Human antitransforming growth factor beta(2) monoclonal antibody-a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. Ophthalmology. 2002;109: 427-431.
39. Zhang XH, Sun NX, Feng ZH, Wang C, Zhang Y, Wang JM. Interference of Y-27632 on the signal transduction of transforming growth factor beta type 1 in ocular Tenon capsule fibroblasts. Int J Ophthalmol. 2012;5:576-581.
40. Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol. 1996;121:349-366.
41. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 2008;5:115-119.
42. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593-601.
43. Kurashige J, Kamohara H, Watanabe M, et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 2012; 19(suppl 3):S656-S664.
44. Yao CX, Wei QX, Zhang YY, et al. miR-200b targets GATA-4 during cell growth and differentiation. RNA Biol. 2013;10: 465-480.
45. Wang B, Koh P, Winbanks C, et al. miR-200a Prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes. 2011;60:280-287.
46. Chen Y, Xiao Y, Ge W, et al. miR-200b inhibits TGF-beta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis. 2013;4: e541.